Since KLK7 is overexpressed in human pancreatic ductal adenocarcinomas and cervical cancer cells (Raju, Kaushal, & Haun, 2016), it appears to be an interesting target for specific protease inhibitors (Prassas et al., 2015). This evidence concerns the gene KLK7 and cervical carcinoma.